Skip to content
ModernDocHealth
Contact

Skip to section

Rheumatology

What the Latest Research Reveals

Data last updated: 25 studies cited

How this page is produced

Generated by the ModernDoc Research Monitor from peer-reviewed literature. Every statistic is automatically checked against its cited source and screened for retractions before it is published. This page is AI-generated and has not yet been reviewed by a clinician — it is not medical advice. Read how we build and check these pages.

43%
Increased risk of autoimmune disease after COVID-19
— affecting multiple organ systems
Source: Chang et al.. EClinicalMedicine (Lancet) (2023). 10.1016/j.eclinm.2022.101783 | n=3800000

KEY FINDINGS

Rheumatoid Arthritis
+98%
95% CI: HR 1.98 (95% CI: 1.72-2.28)
Source [4]
Inflammatory Myopathy
+117%
95% CI: HR 2.17 (95% CI: 1.41-3.35)
Source [6]
Systemic Lupus
+62%
95% CI: HR 1.62 (95% CI: 1.31-2.01)
Source [2]
Antiphospholipid Antibodies
52%
95% CI: Prevalence in hospitalized patients (95% CI: 44-60%)
Source [7]

THE TIMELINE

Acute Phase

0-2 weeks

Broad, low-specificity autoantibodies; thrombosis risk from aPL

Key Event
Cytokine storm and autoantibody induction

Autoimmune Disease Risk Increase

Source: Chang et al., EClinicalMedicine 2023; HR ~1.1 for influenza vs HR 1.43 for COVID-19

Cumulative Risk with Reinfection

1 infection+43%
Reinfection+Additive
Multiple+Cumulative

“Each infection may contribute additional autoimmune risk through epitope spreading”

THE HOPEFUL HORIZON

  • Vaccination reduces autoimmune risk: OR 0.62 for flares with 3+ doses[10]
  • Majority of autoantibodies decline by 3-12 months post-infection[10]
  • Remission pre-COVID is protective: OR 0.54 for disease flares[10]
  • Methotrexate monotherapy shows protective effect: OR 0.78 for flares[10]

SOURCES

  1. [1]Chang R, Yen-Ting Chen T, Wang SI, Hung YM, Chen HY, Wei CJ. Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study. EClinicalMedicine (Lancet). 2023;56:101783. DOI (opens in new tab)
  2. [2]Gracia-Ramos AE, Martin-Nares E, Hernandez-Molina G. New onset of autoimmune diseases following COVID-19 diagnosis. RMD Open. 2023;9:e002730. DOI (opens in new tab)
  3. [3]Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nature Reviews Microbiology. 2023;21:133-146. DOI (opens in new tab)
  4. [4]Tesch F, Ehm F, Vivirito A, et al. Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study. Annals of the Rheumatic Diseases. 2023;82:1423-1430. DOI (opens in new tab)
  5. [5]Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nature Medicine. 2022;28:583-590. DOI (opens in new tab)

See a problem with the Rheumatology research summary?

Send a source correction or freshness concern. We cannot provide personal medical advice through this site.

Report a correction

SHARE THIS INFORMATION

Share with someone who needs to know

Back to DashboardReport an Issue

Data last updated:

Medical review: AI-generated — pending clinician review

Sources cited: 25 peer-reviewed sources

Claim verification: 0/0 verified (NaN%)

About DOIs

This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for medical decisions. Data is sourced from peer-reviewed publications and may be updated as new research emerges.